Physician

Carter E Tharpe, M.D.

According to 2025 Medicare claims, Carter Tharpe, M.D. (NPI: 1972547651) practices cardiology in the Macon-Bibb County, GA market, with the plurality of this provider's patient population coming from Bibb, GA. This provider's primary affiliated billing organization is CENTRAL GEORGIA HEART CENTER, PC (NPI: 1780779363; TIN: 582149128) and primary practice location at 31201-8638. Tharpe is affiliated with the TC2, LLC (ACO ID: A3365), participating under the MSSP model.

Tharpe's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,038 traditional Medicare patients, billed 6,721 HCPCS/CPT codes, and received $660,631 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 7,897 prescription claims across 1,352 beneficiaries totaling $1,333,539 in drug costs, led by Eliquis (Apixaban). 2017 DME data shows 22 claims. Open Payments data shows 16 records totaling $378. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $566,186 to $1,333,539. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,795	8,726	$663,682
2016	2,896	10,245	$879,946
2017	2,916	10,098	$990,356
2018	2,881	9,474	$837,981
2019	2,589	8,369	$772,553
2020	2,245	7,215	$711,791
2021	2,238	7,378	$753,542
2022	2,264	7,267	$768,587
2023	2,095	7,360	$834,722
2024	2,038	6,721	$660,631

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	839	8,698	$566,186
2016	953	9,429	$744,348
2017	1,043	9,183	$728,121
2018	1,049	8,680	$831,239
2019	1,062	7,593	$988,092
2020	1,084	7,733	$1,047,109
2021	1,172	7,967	$1,277,370
2022	1,174	7,602	$1,377,912
2023	1,212	7,453	$1,379,272
2024	1,352	7,897	$1,333,539

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	35	$1,465
2017	N/R	22	$559
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	673	690	$101
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	420	463	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	686	719	$57
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	279	279	$48
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	1,083	1,177	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	417	23,724	$456,719
Entresto	Sacubitril/Valsartan	282	13,136	$278,591
Xarelto	Rivaroxaban	200	10,425	$190,482
Repatha Sureclick	Evolocumab	99	4,104	$78,745
Farxiga	Dapagliflozin Propanediol	53	2,664	$49,733

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$378	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Carter E. Tharpe, M.D.?

Tedicare shows public-source Medicare data for Carter E. Tharpe, M.D. (NPI 1972547651), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carter E. Tharpe, M.D. have ACO affiliation data?

Carter E. Tharpe, M.D. is shown with ACO affiliation data for TC2, LLC (MSSP, ACO ID A3365).

What billing organization is linked to Carter E. Tharpe, M.D.?

Carter E. Tharpe, M.D. is linked to CENTRAL GEORGIA HEART CENTER, PC (billing NPI 1780779363) in the available physician profile data.

Does Carter E. Tharpe, M.D. have Open Payments data?

Carter E. Tharpe, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.